{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,14]],"date-time":"2025-10-14T00:59:53Z","timestamp":1760403593068,"version":"build-2065373602"},"reference-count":21,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,11,30]],"date-time":"2022-11-30T00:00:00Z","timestamp":1669766400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100006483","name":"AbbVie","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006483","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Antimicrobial Agents"],"published-print":{"date-parts":[[2023,1]]},"DOI":"10.1016\/j.ijantimicag.2022.106698","type":"journal-article","created":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T21:35:20Z","timestamp":1669930520000},"page":"106698","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["In Vitro Selection of Enterobacter cloacae with Cefepime, Meropenem, and Ceftazidime-Avibactam Generates Diverse Resistance Mechanisms"],"prefix":"10.1016","volume":"61","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0126-1782","authenticated-orcid":false,"given":"Mariana","family":"Castanheira","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jill","family":"Lindley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Timothy B.","family":"Doyle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0717-6087","authenticated-orcid":false,"given":"Andrew P.","family":"Davis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Helio S.","family":"Sader","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijantimicag.2022.106698_bib0001","doi-asserted-by":"crossref","first-page":"e00002","DOI":"10.1128\/CMR.00002-19","article-title":"Enterobacter spp.: Update on taxonomy, clinical aspects, and emerging antimicrobial resistance","volume":"32","author":"Davin-Regli","year":"2019","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.ijantimicag.2022.106698_bib0002","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1086\/533452","article-title":"Federal funding for the study of antimicrobial resistance in nosocomial pathogens: no ESKAPE","volume":"197","author":"Rice","year":"2008","journal-title":"J Infect Dis"},{"key":"10.1016\/j.ijantimicag.2022.106698_bib0003","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1086\/595011","article-title":"Bad bugs, no drugs: no ESKAPE! An update from the Infectious Diseases Society of America","volume":"48","author":"Boucher","year":"2009","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2022.106698_bib0004","doi-asserted-by":"crossref","first-page":"S20","DOI":"10.1016\/j.ajic.2006.05.238","article-title":"Resistance in gram-negative bacteria: Enterobacteriaceae","volume":"34","author":"Paterson","year":"2006","journal-title":"Am J Infect Control"},{"issue":"3","key":"10.1016\/j.ijantimicag.2022.106698_bib0005","doi-asserted-by":"crossref","first-page":"dlab136","DOI":"10.1093\/jacamr\/dlab136","volume":"3","author":"Sader","year":"2021","journal-title":"JAC Antimicrob Resist"},{"key":"10.1016\/j.ijantimicag.2022.106698_bib0006","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1128\/CMR.00036-08","article-title":"AmpC beta-lactamases","volume":"22","author":"Jacoby","year":"2009","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.ijantimicag.2022.106698_bib0007","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1128\/CMR.00043-12","article-title":"Adaptive and mutational resistance: role of porins and efflux pumps in drug resistance","volume":"25","author":"Fernandez","year":"2012","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.ijantimicag.2022.106698_bib0008","doi-asserted-by":"crossref","first-page":"392","DOI":"10.3389\/fmicb.2015.00392","article-title":"Enterobacter aerogenes and Enterobacter cloacae; versatile bacterial pathogens confronting antibiotic treatment","volume":"6","author":"Davin-Regli","year":"2015","journal-title":"Front Microbiol"},{"key":"10.1016\/j.ijantimicag.2022.106698_bib0009","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.1093\/cid\/ciz173","article-title":"A primer on AmpC beta-lactamases: Necessary knowledge for an increasingly multidrug-resistant world","volume":"69","author":"Tamma","year":"2019","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2022.106698_bib0010","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1093\/jac\/dkv346","article-title":"Carbapenems versus alternative antibiotics for the treatment of bloodstream infections caused by Enterobacter, Citrobacter or Serratia species: A systematic review with meta-analysis","volume":"71","author":"Harris","year":"2016","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2022.106698_bib0011","doi-asserted-by":"crossref","first-page":"887","DOI":"10.2217\/fmb.12.61","article-title":"Enterobacter cloacae complex: Clinical impact and emerging antibiotic resistance","volume":"7","author":"Mezzatesta","year":"2012","journal-title":"Future Microbiol"},{"key":"10.1016\/j.ijantimicag.2022.106698_bib0012","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1002\/phar.1622","article-title":"The beta-Lactams strike back: Ceftazidime-avibactam","volume":"35","author":"Zasowski","year":"2015","journal-title":"Pharmacother"},{"key":"10.1016\/j.ijantimicag.2022.106698_bib0013","doi-asserted-by":"crossref","first-page":"27960","DOI":"10.1074\/jbc.M113.485979","article-title":"Kinetics of avibactam inhibition against Class A, C, and D beta-lactamases","volume":"288","author":"Ehmann","year":"2013","journal-title":"J Biol Chem"},{"key":"10.1016\/j.ijantimicag.2022.106698_bib0014","doi-asserted-by":"crossref","first-page":"3053","DOI":"10.1093\/jac\/dky279","article-title":"Frequency and antimicrobial susceptibility of Gram-negative bacteria isolated from patients with pneumonia hospitalized in ICUs of US medical centres (2015-17)","volume":"73","author":"Sader","year":"2018","journal-title":"J Antimicrob Chemother"},{"year":"2018","series-title":"Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically: eleventh edition M07","key":"10.1016\/j.ijantimicag.2022.106698_bib0015"},{"key":"10.1016\/j.ijantimicag.2022.106698_bib0016","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1089\/cmb.2012.0021","article-title":"SPAdes: a new genome assembly algorithm and its applications to single-cell sequencing","volume":"19","author":"Bankevich","year":"2012","journal-title":"J Comput Biol"},{"key":"10.1016\/j.ijantimicag.2022.106698_bib0017","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/gigascience\/gix001","article-title":"The use of Oxford Nanopore native barcoding for complete genome assembly","volume":"6","author":"Bayliss","year":"2017","journal-title":"Gigascience"},{"key":"10.1016\/j.ijantimicag.2022.106698_bib0018","doi-asserted-by":"crossref","first-page":"4774","DOI":"10.1128\/JB.187.14.4774-4781.2005","article-title":"The ubiquitous protein domain EAL is a cyclic diguanylate-specific phosphodiesterase: enzymatically active and inactive EAL domains","volume":"187","author":"Schmidt","year":"2005","journal-title":"J Bacteriol"},{"key":"10.1016\/j.ijantimicag.2022.106698_bib0019","doi-asserted-by":"crossref","first-page":"e01273","DOI":"10.1128\/AAC.01273-20","article-title":"Systematic investigation of resistance evolution to common antibiotics reveals conserved collateral responses across common human pathogens","volume":"65","author":"Rodriguez de Evgrafov","year":"2020","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2022.106698_bib0020","doi-asserted-by":"crossref","first-page":"516","DOI":"10.3389\/fmicb.2015.00516","article-title":"MioC and GidA proteins promote cell division in E. coli","volume":"6","author":"Lies","year":"2015","journal-title":"Front Microbiol"},{"key":"10.1016\/j.ijantimicag.2022.106698_bib0021","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1016\/j.chom.2013.05.009","article-title":"Microbial persistence and the road to drug resistance","volume":"13","author":"Cohen","year":"2013","journal-title":"Cell Host Microbe"}],"container-title":["International Journal of Antimicrobial Agents"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857922002242?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857922002242?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T17:44:30Z","timestamp":1760377470000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924857922002242"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1]]},"references-count":21,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023,1]]}},"alternative-id":["S0924857922002242"],"URL":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2022.106698","relation":{},"ISSN":["0924-8579"],"issn-type":[{"type":"print","value":"0924-8579"}],"subject":[],"published":{"date-parts":[[2023,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"In Vitro Selection of Enterobacter cloacae with Cefepime, Meropenem, and Ceftazidime-Avibactam Generates Diverse Resistance Mechanisms","name":"articletitle","label":"Article Title"},{"value":"International Journal of Antimicrobial Agents","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2022.106698","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"106698"}}